Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022

Sector:

• Personalized medicine

Sub-sector:

Technologies and products of particular interest in this mission include:

• biologics and advanced therapies regardless of treatment area
• antibody-based therapeutics and other targeted biologics
• advanced therapies (cell and gene therapies; CAR-T cells, tissue engineered therapies, etc.)
• lipid nanoparticle (LNP) with genetic medicine payloads (mRNA, siRNA, CRISPR, etc)

Open to: Small and medium-sized enterprises

Deadline to apply: September 9, 2022

More information: Consult the detailed request for expression of interest

Related program: Canadian International Innovation Program